Trials / Completed
CompletedNCT05432011
PENG Block Plus Lateral Femoral Cutaneous Nerve Block for Posterolateral-approached Total Hip Arthroplasty
PENG Block Combined to Lateral Femoral Cutaneous Nerve Block vs. PENG Block Combined to Wound Infiltration for Postoperative Analgesia Following Posterolateral-approached Total Hip Arthroplasty
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Campus Bio-Medico University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to analyze the effect of Pericapsular Nerve Group (PENG) Block combined with lateral femoral cutaneous nerve block vs. PENG block combined with wound infiltration for analgesia after elective hip replacement performed with a posters-lateral approach. Half of participants will receive a PENG Block combined with femoral lateral cutaneous nerve block, while the other half will receive PENG Block combined with wound infiltration
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PENG Block | At the end of surgery, in Post Anesthesia Recovery Room (PACU), PENG block with 20 mL of 0.5 % Ropivacaine will be executed as described by Giron-Arango et al. using a low frequency curvilinear probe. A 22G 80 mm needle (Stimuplex Ultra 360, B.Braun) will be used. |
| PROCEDURE | Lateral Femoral Cutaneous Nerve Block | At the end of surgery, in Post Anesthesia Recovery Room (PACU), ultrasound guided Lateral Femoral Cutaneous Nerve Block will be performed with 10 mL of 0.5 % Ropivacaine using a high frequency linear probe. A 22G 50 mm needle (Stimuplex Ultra 360, B.Braun) will be used. |
| PROCEDURE | Wound Infiltration | At the end of operation, the surgeon will perform wound infiltration with 20 mL of 0.5 % Ropivacaine. |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2023-05-18
- Completion
- 2023-05-25
- First posted
- 2022-06-24
- Last updated
- 2023-08-30
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05432011. Inclusion in this directory is not an endorsement.